Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

62.98
-1.7700-2.73%
Post-market: 62.80-0.1800-0.29%19:46 EST
Volume:714.70K
Turnover:45.06M
Market Cap:4.46B
PE:-17.24
High:65.05
Open:64.13
Low:62.17
Close:64.75
52wk High:94.90
52wk Low:13.22
Shares:70.84M
Float Shares:51.39M
Volume Ratio:0.91
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6529
EPS(LYR):-2.3276
ROE:-25.28%
ROA:-17.53%
PB:5.79
PE(LYR):-27.06

Loading ...

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Goldman Sachs

TIPRANKS
·
Jan 20

24H | Springview Rockets Another 16% After a 674% Rally; GPCR Jumps 6% as It Expects Pills to Capture up to 50% of GLP-1 Obesity Market; Hesai Gains 3%

Tiger Newspress
·
Jan 16

Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments

Benzinga_recent_news
·
Jan 16

Structure Therapeutics CEO Voices Concerns Over Generic Competition for Weight-Loss Drugs: Challenges Loom Even Before Market Approval

Stock News
·
Jan 15

Structure expects pills to capture up to 50% of GLP-1 obesity market by 2030

Reuters
·
Jan 15

Structure Therapeutics CEO Expects Pills to Capture 25% to 50% of Glp-1 Weight-Loss Market by 2030

THOMSON REUTERS
·
Jan 15

Structure Therapeutics CEO Says Strategic Partner for Commercialization of Its Medicine Needs to Have Strong Relationships With Primary Care Doctors

THOMSON REUTERS
·
Jan 15

What to Watch in the Day Ahead - Wednesday, January 14

Reuters
·
Jan 14

Structure Therapeutics rises 14.1%

TIPRANKS
·
Jan 14

What to Watch in the Day Ahead - Tuesday, January 13

Reuters
·
Jan 13

Funding for Risky Biotechs Is Returning -- WSJ

Dow Jones
·
Jan 13

Structure Therapeutics Inc. unveils oral obesity treatment pipeline in new corporate presentation

Reuters
·
Jan 13

Septerna to Present GPCR Pipeline Updates at JPM Conference

TIPRANKS
·
Jan 12

Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

Dow Jones
·
Jan 09

Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress
·
Jan 07

Weight-Loss Drugmakers' Stocks Jump. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up Around 2%

Tiger Newspress
·
Jan 06

BRIEF-Structure Therapeutics Inc - Gasherbrum Entered Agreement With Genentech And Roche - SEC Filing

Reuters
·
Jan 06

Structure Therapeutics Inc - Genentech to Pay Gasherbrum $100 Mln - SEC Filing

THOMSON REUTERS
·
Jan 06

Structure Therapeutics Subsidiary Grants Genentech $100 Million License for GLP-1 Patents

Reuters
·
Jan 06

The Year-End 2025 Biotech Rally And What It Means For 2026

Benzinga_recent_news
·
Dec 31, 2025